NCT06768112

Brief Summary

This three-year research proposal aims to enhance postural control in older adults using non-invasive vagus nerve stimulation (nVNS). The study will develop a new system integrating cerebellar EEG (ECeG), EEG, and ECG to assess how nVNS combined with postural training affects individuals with early-stage frontal degeneration. In the first year, the focus will be on creating and validating the ECeG system to explore neural mechanisms of postural control. The second year will test the combined effects of ear-nVNS and dynamic posture training, examining how nVNS influences adrenal and hormone pathways. The final year will evaluate if ear-nVNS can further improve postural training with virtual feedback. Overall, the project aims to advance fall prevention strategies for older adults by exploring the role of cerebellar function and innovative training methods.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
21mo left

Started Aug 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Aug 2024Dec 2027

Study Start

First participant enrolled

August 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 12, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

January 10, 2025

Status Verified

September 1, 2024

Enrollment Period

3.2 years

First QC Date

September 12, 2024

Last Update Submit

January 6, 2025

Conditions

Keywords

Gual-taskInvasive cervical vagus nerve stimulationAgingCerebellar EEG

Outcome Measures

Primary Outcomes (3)

  • Cognitive Performance

    Analysis of cognitive tests including Stroop test and trail making test.

    the first day, at the end of 5 days training

  • Brain activity

    EEG Data Analysis

    the first day, at the end of 5 days training

  • Kinematic Analysis of Upper and Lower Limb Dynamics

    Participants are asked to stand with both feet on a soft-pad and try to maintain a stable posture with minimal body sway. The center of pressure trajectory are taken to estimate behavioral and neurophysiological mechanisms. The dual-task involves performing simultaneous tasks of tapping LED sensor lights in real-time while standing on the soft-pad force plate.

    the first day, at the end of 5 days training

Other Outcomes (1)

  • Mini-Mental State Examination; MMSE

    Before participating in the formal protocol, each subject must take the Mini-Mental State Examination to assess their cognitive level. This test is conducted only once per subject.

Study Arms (2)

Placebo

PLACEBO COMPARATOR

participants in this arm will conduct balance training without non-invasive vagal nerve stimulation.

Behavioral: balance trainingBehavioral: Mini-Mental State Examination

non-invasive vagal nerve stimulation

EXPERIMENTAL

Participants will receive non-invasive vagal nerve stimulation and balance training

Device: Non-Invasive Vagus Nerve StimulationBehavioral: balance trainingBehavioral: Mini-Mental State Examination

Interventions

Using non-invasive vagus nerve stimulation at the ear to stimulate the adrenergic and serum hormone pathways, activating the frontal lobe system, sensory-motor nervous system, and cerebellum, to investigate the effects and neural mechanisms of dynamic posture training and learning.

non-invasive vagal nerve stimulation

Participants will be asked to stand on a soft-platform and hit on blaze-pod LED within 60 seconds.

Placebonon-invasive vagal nerve stimulation

The mini-mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.

Placebonon-invasive vagal nerve stimulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Participants aged 18-45 years (young adults) and 60-80 years (older adults).
  • Vision should be within the normal range after visual correction.
  • Lower limb strength requirement: Ability to climb stairs without holding onto anything, able to ascend 15 steps (a typical office building floor has approximately 15-20 steps).
  • No history of falls in the past six months.

You may not qualify if:

  • Here is the translation of the provided text:
  • Young adult participants: Exclude students from the Department of Physical Therapy, School of Medicine, and Institute of Behavioral Medicine at National Cheng Kung University.
  • Uncontrolled cardiovascular diseases (e.g., hypertensive patients with resting systolic blood pressure exceeding 160 mmHg).
  • Lower limb venous embolism, arterial calcification, and lymphatic issues.
  • Diabetes, sickle cell anemia, coagulation disorders, dialysis patients, and those with conditions affecting walking, lower limb musculoskeletal function, and balance issues.
  • No known psychiatric, neuromuscular, or degenerative neurological diseases.
  • Hearing impairment or those using hearing aids.
  • Dizziness caused by any lesions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Chen Kong University Hospital

Tainan, Taiwan

Location

MeSH Terms

Interventions

Mental Status and Dementia Tests

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2024

First Posted

January 10, 2025

Study Start

August 1, 2024

Primary Completion (Estimated)

October 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

January 10, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations